Cannabis Life Sciences CEO Andrew Glashow is our guest this episode. We look at trends in the marijuana industry and what he sees ahead for the sector.
Equity indices are making all-time highs with record amounts of money pulled from stock funds and ETFs – how does that square?
Plus, we take a look at earnings and economics for the coming week ahead.
Mr. Glashow has twenty-five years of experience in the capital markets and in all phases of business start-up and growth, including feasibility studies, business plans, equity and debt funding, private placements, reverse mergers and IPOs. Mr. Glashow has served as CEO and President of multiple companies which he helped capitalize. He is a graduate of the University of New Hampshire’s Whitemore School of Business and Economics.
About CLS Holdings:
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for “Cannabis Life Sciences,” in recognition of the Company’s patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company’s business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
More information on the TDI Managed Growth Strategy – HERE
Friday Pre-Market Run-Down Webinar Registration
Stocks mentioned in this episode: (CLSH)
Podcast: Play in new window | Download (Duration: 39:20 — 36.0MB)
